ReviewCurrent opinion in ophthalmology2013
Pediatric uveitis: new and future treatments.
Review in Current opinion in ophthalmology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 32 citations in OpenAlex.
- Clinical features and the impact of MEFV Variants in pediatric non-infectious uveitis: a retrospective single-center study.Clinical rheumatology · 2026Article
- The Efficacy of Adalimumab Treatment in Pediatric Non-Infectious Uveitis: A Retrospective Cohort Study.Turkish journal of ophthalmology · 2024Article
- Experiences of burden and needs in caregivers with pediatric noninfectious uveitis: a qualitative study.BMC nursing · 2024Article
- Incidence and Prevalence of Pediatric Noninfectious Uveitis in Korea: A Population-Based Study.Journal of Korean medical science · 2022Article
- Myopia and Other Visual Disorders in Children.International journal of environmental research and public health · 2022Article
- Update on biologic therapies for juvenile idiopathic arthritis-associated uveitis.Annals of eye science · 2021Article
- Patterns of uveitis in children according to age: comparison of visual outcomes and complications in a tertiary center.BMC ophthalmology · 2019Article
- Update on the management of uveitis in children: an overview for the clinician.Expert review of ophthalmology · 2019Article
- A child with tubulointerstitial nephritis and uveitis (TINU) syndrome.BMJ case reports · 2018Article
- An Update on Treatment of Pediatric Chronic Non-Infectious Uveitis.Current treatment options in rheumatology · 2017Article
- The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study.Pediatric rheumatology online journal · 2015Article
- Dexamethasone intravitreal implant (Ozurdex®) for pediatric uveitis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2015Article
- Management of pediatric uveitis.F1000prime reports · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
purpose of reviewPediatric uveitis is relatively uncommon, accounting for only 5-10% of all patients with uveitis. However, owing to high prevalence of complications and devastating outcomes, its lifetime burden can be significant. RECENT
findingsImmunomodulatory therapy has been associated with better outcomes in noninfectious pediatric uveitis. However, effective treatments are limited by medication-related complications, including multiorgan toxicities and systemic side effects. SUMMARY: We review the current therapies available to treat pediatric uveitis, discuss novel and future therapies, and provide clinical recommendations utilizing these new agents. The consideration for treatment regimens in noninfectious pediatric uveitis is multifactorial. Understanding past, present, and future technology will aid in treatment of a complex and refractory disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.